Titan Pharmaceuticals Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Titan Pharma (TTNP) Reports Q2 Loss of $0.11, Revenues Beat
November 14, 2018 4:21 PM ESTTitan Pharma (NASDAQ: TTNP) reported Q2 EPS of ($0.11), versus ($0.20) reported last year. Revenue for the quarter came in at $1.6 million versus the consensus estimate of $100 thousand.
"In order to maximize the significant market opportunity represented by our lead product, Probuphine®, we were... More
